S
tem cell therapy is a potential therapeutic option for treating ischemic cardiovascular diseases. Several types of adult stem or progenitor cells have been shown to improve recovery after ischemic damage and contribute to vasculogenesis and possibly cardiomyogenesis, bone marrow-derived cells being the most extensively studied to date. Overall, the clinical trials using bone marrow-derived cells for patients with acute or chronic ischemic heart disease demonstrated the safety of the procedure and generally documented improvements of heart function and clinical outcome. [1] [2] [3] [4] [5] However, the increase in contractile recovery was modest in most trials (for review see the recent metaanalysis of Lipinski et al 6 ). The modest effects of the transplanted cells have been attributed to rather low engraftment and survival as well as their limited cardiomyogenic capacity. 7, 8 Additionally, increasing age and risk factors for coronary artery disease significantly reduce the functional activity of bone marrow-derived and circulating cells in patients. 9 -11 Aging is known to affect stem/progenitor cell function in animal models and may lead to exhaustion of the endogenous stem cell pools. 12 Therefore, we investigated whether subsets of circulating progenitor cells might exist during early human postnatal development and during childhood. In the circulating blood of adults, different subsets of hematopoietic progenitor cells, endothelial progenitor cells and -after mobilization-mesen-chymal stromal cells (MSCs) have already been described. [13] [14] [15] Here, we identified multipotent, clonally expandable, telomerase-positive circulating cells in the blood of children, which are distinct from previously identified circulating hematopoietic and endothelial progenitor cells. The isolated cells can be induced to differentiate to the principle cell types of 3 cardiovascular lineages and form skeletal muscle. Phenotypically, the isolated cells resemble previously described vessel-associated mesoangioblasts. 16 The isolated cells express 3 of the 4 pluripotency genes 17 that have been shown to reprogram somatic cells to pluripotency (reviewed by Nishikawa et al 18 ) , namely Klf-4, c-Myc, and low levels of Oct3/4. The cells however lack Sox2 expression. We therefore reasoned that complementation with Sox2 may be sufficient to enhance the differentiation capacity of these blood-derived mesoangioblast-like cells. Thus, we investigated the phenotypic and functional consequences of ectopic Sox2 expression.
Methods

Cell Isolation and Culture From Human Peripheral Blood
Blood samples were collected from patients who underwent open heart surgery with cardiopulmonary bypass. The ethics review boards of the universities Giessen and Marburg, and Frankfurt approved the protocol, and the study was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from each patient or patient's parent. Mononuclear cells were isolated by Ficoll density gradient centrifugation. Detailed protocols are available in the expanded Methods section, available in the Online Data Supplement at http://circres.ahajournals.org.
Myocardial Infarction, Cell Injection, and Functional Evaluation
Myocardial infarction was induced by permanent ligation of the left coronary artery in 10-to 12-week-old athymic NMRI nude mice (Harlan). Soon after ligation, animals were randomized to receive 1ϫ10 6 cells or PBS (both 50 L), which were injected intramuscularly into the border zone at 3 different sites. After 2 weeks (for unmodified cell injection; Figure 3 ) and 4 weeks (green fluorescent protein [GFP] and Sox2 transduction; Figure 7 ), cardiac catheterization was performed for functional analysis by using 1.4F micromanometer-tipped conductance catheter (Millar Instruments Inc). Left ventricular pressure and its derivative were continuously monitored with a multiple recording system. Then the data were confirmed in a second group of mice using noninvasive monitoring of cardiac function by high quality echocardiography at day 0, day 14, and day 28. All data were acquired under stable hemodynamic conditions.
Preparation of Lentiviral Stocks
Preparation of lentiviral stocks were performed as described. 19 In brief, self-inactivating lentiviral vectors containing the enhanced GFP gene, ␣ myosin heavy chain (MHC) promoter (accession number: U71441) GFP, endothelial NO synthase (eNOS) promoter (accession number: AF387340) GFP, or the human SOX2 gene under the control of a spleen focus-forming virus promoter were generated by transient transfection of 293T cells using pCMV⌬R8.91 as packaging plasmid and pMD2.G for vesicular stomatitis virus-G protein (VSV-G) pseudotyping. After 8 hours, the medium was replaced by EBM supplemented with EGM SingleQuots and 20% FBS. The supernatant was collected every 24 hours for 2 days, pooled (200 to 250 mL), and filtered through 0.22-m filters.
Lentiviral Transduction
For lentiviral transduction, isolated cells were transduced at the second to third passage. Transduction was carried out by adding viral supernatant to the EBM supplemented with EGM SingleQuots and 20% FBS. After 6 hours, medium was changed and the cells were transduced a second time.
All other methods are outlined in detail in the Online Data Supplement.
Results
Characterization of Blood-Derived Progenitor Cells in Children
Blood-derived circulating mononuclear cells were obtained from individuals undergoing cardiopulmonary bypass for cardiac surgery. Cells were cultivated on fibronectin-coated dishes and first clones were detected after 1 to 2 weeks ( Figure 1A) . Overall, 1.1 to 2.1 colonies were detected per ml blood after 2 weeks of culture. Cells isolated from the first sequential 12 patients (8 children and 4 adults) were continuously cultured to define the long term proliferation capacity ( Figure 1 and Online Table I ). Cells showed a spindle-shaped morphology ( Figure 1A ), exhibited a high proliferative capacity, and were cultured for 24.6Ϯ1.7 passages ( Figure 1B ). The proliferative capacity was highly correlated with the donor age ( Figure 1C ) and was associated with high telomerase activity, which was detected at least until the 15th passage ( Figure 1D ; Online Figure I, A) . Onset of senescence, as determined by acidic ␤-galactosidase staining, started after the 20th passage (0.25%) and approximately 10% acidic ␤-galactosidase-positive cells were detected after 29 passages ( Figure 1A) . Characterization of the surface marker expression by flow cytometry and RT-PCR revealed that the cultivated cells express the mesenchymal markers CD13, CD73, and CD44, the endothelial markers CD105, Tie2, and KDR (type II vascular endothelial growth factor receptor), but were negative for the endothelial/hematopoietic marker CD31 and the hematopoietic markers CD34, CD133, and CD45 ( Figure 1E and 1F). Online Table II 20 ) , multipotent adult progenitor cells, 21 and umbilical cord-derived unrestricted stem cells (for summary, see Online Table III) . 22 Moreover, Koyanagi et al Sox2 Improves Regeneration Capacity of cMABsalthough the cells were CD105 ϩ KDR ϩ , the absence of CD31 and lack of the hematopoietic markers CD34 and CD45 distinguish the cultivated juvenile cells from circulating endothelial and hematopoietic progenitor cells ( Figure 1F and elsewhere [23] [24] [25] ). When comparing the marker expression profile to previously described cells, these children-derived cells resemble mesoangioblasts, which are multipotent progenitors of mesodermal tissue originally isolated from the embryonic dorsal aorta and characterized by the expression of mesenchymal and endothelial markers. 26 Consistent with the phenotype of mesoangioblasts isolated from adult tissue, 27 children-derived cells expressed the proteoglycan NG2, a marker for pericyte-derived cells (Online Figure I, B) .
Blood-Derived Mesoangioblasts Can Be Clonally Expanded
To elucidate whether the cells can be grown clonally from single cells, we performed limiting dilution assays using cells from the second to third passage. The clonal efficiency estimated by single cell deposition was 9.5Ϯ2.0%. Eighteen expanded single cell-derived clones were further characterized, and all clones showed the characteristic expression of CD73 and KDR but lacked expression of CD45 ( Figure 1H and 1I). To determine whether the cultured cells indeed originate from CD73 ϩ circulating cells, we sorted CD73 ϩ and CD73 Ϫ cells from peripheral blood mononuclear cells before culturing the cells. The number of colonies was 10.3 times higher when CD73 ϩ cells were used as starting population for the culture compared to nonsorted cells, whereas only very few colonies were occasionally observed in the CD73 Ϫ fraction (Online Figure I , C). These data suggest that the expression of CD73 indeed defines circulating mesoangioblast (cMAB).
Differentiation of Blood-Derived Mesoangioblasts
Next, we assessed the lineage-directed differentiation potential by culturing the isolated cells (third to fifth passage) under conditions favoring endothelial, smooth or skeletal Lectin was intravenously injected to detect perfused vessels. Barϭ200 m. D, RT-PCR of Fli-1 and HEX in peripheral blood-derived cMABs isolated from 2 children; and adult MAB obtained from human aorta, human heart, and HUVECs are shown as control. H 2 O served as negative control. E, Immunofluorescence image of cMAB differentiated to smooth muscle cells in vitro. TGF␤1 or Jagged-1, heparin, and fibroblast growth factor 8 (FGF8) were used as stimulus for 1 or 14 days. The day 1 sample was used as negative control. Bar, 100 m. NՆ3 donors. F, Cells were cultured on atelocollagen type 1 membrane. Rat cardiomyocytes were cocultured at the opposite side of the membrane. cMABs were stained with ␣-sarcomeric actinin after 10 days. Bar, 100 m. factors Hex and Fli-1, known to play a key role in vascular development, 28, 29 were highly expressed ( Figure 2D ). Differentiation into smooth muscle cells was induced by addition of transforming growth factor (TGF)␤1, whereas cultivation of the cells on dishes coated with Jagged-1 protein in combination with fibroblast growth factor 8 induced the expression of smooth muscle-specific proteins in Ͼ60% of all cells ( Figure  2E ; Online Figure III, A) . The mRNA expression of the muscle marker smooth muscle actin was additionally documented (Online Figure III, B) . Skeletal muscle differentiation was tested by coculturing human mesoangioblasts with C2C12 mouse myogenic cells and scoring the % of human nuclei fused into myotubes. As reported in Online Figure IV , more than 10% of human nuclei fused with mouse myoblasts indicating a significant myogenic potency, even though, as in embryonic mouse mesoangioblasts, spontaneous myogenesis did not occur. 16 To induce differentiation into the cardiac lineage, we incubated mesoangioblasts with Wnt3a, which was previously shown to promote cardiac differentiation of embryonic stem cells. 30, 31 Wnt3a increased the expression of ␣-MHC in vitro (Online Figure V, A) . Furthermore, when blood-derived mesoangioblasts were cocultured with neonatal rat cardiomyocytes for 6 days 32,33 they acquired features of cardiomyocytes as demonstrated by the expression of ␣-sarcomeric actinin by immunostaining (Online Figure V, B) and human troponin T mRNA using human specific primers designed to span the region from exon 6 to exon 10 (Online Figure V, C) . The identity of the human troponin T was confirmed by sequencing (Online Figure V, C) . The increase in the extent of cardiac differentiation in terms of troponin T expression levels after 6 days of coculture with rat cardiomyocytes, as assessed by RT-PCR, was 8-fold higher compared to endothelial progenitor cells used in similar previous studies (data not shown). Furthermore, we cultured embryonic body-like structure from 10000 GFP-transduced cells by using the hanging drop technique and then cocultured the embryonic bodies with neonatal rat cardiomyocytes. GFP-positive cells contracted after 10 days of culture (see Online Figure  VI and Movie I). In addition, using a modified coculture assay with type I atelocollagen membrane to separate the mesoangioblasts and neonatal cardiomyocytes and exclude fusion, 34 mesoangioblasts differentiated to ␣-sarcomeric actinin positive cardiomyocytes after 10 days of culture ( Figure 2F ).
In line with these results, mesoangioblasts also expressed various transcription factors important for myogenic differentiation such as GATA-4, Mef-2C, and Tbx5 (Figure 2G and 2H; Online Figure VII, B) . Interestingly, before inducing cardiac differentiation, the children-derived cells strongly expressed Islet-1 ( Figure 2G and 2H) , a transcription factor expressed by multiple cell lineages but also shown previously to define a multipotent primordial cardiovascular progenitor cells during development. 32 The expression of Nkx2.5 was more heterogeneous (Figure 2G and 2H ). Taken together, the blood-derived mesoangioblast-like cells are multipotent and can be directed to differentiate into the 3 distinct cardiovascular cell lineages in vitro.
Transplanted Blood-Derived Mesoangioblasts Differentiate to Endothelial, Smooth Muscle, and Cardiac Muscle in Ischemic Models In Vivo
To determine the potential functional benefit using bloodderived cells for therapeutic applications, human cells were injected in a nude mice model of hind limb ischemia. After 14 days, the recovery of blood flow was significantly greater in mice treated with cMABs compared to PBS-treated control mice ( Figure 3A and 3B) . In addition, cells were injected intramyocardially in mice after induction of myocardial infarction. After 2 weeks, cell-treated mice exhibited a significantly, but modestly improved cardiac function with lower left ventricular end-diastolic pressures (46.2Ϯ11.0% reduction) and improved diastolic function (Tau: 18.2Ϯ5.4% reduction, Figure 3C Moreover, cardiac and endothelial differentiation was confirmed by human specific RT-PCR of troponin T and Tie2, respectively ( Figure 3G ). Survival and retention of human cells was confirmed by human specific GAPDH expression, which was measured by quantitative PCR ( Figure 3H ). In addition to the capacity of the injected cells to contribute to tissue regeneration by differentiation to the cardiovascular cell lineages, cells expressed and secreted a variety of proangiogenic cytokines and cardioprotective factors known to contribute to improved infarct healing (Online Figure X) .
Expression of Stem Cell Markers and Pluripotency Associated Genes in cMABs
Because our results demonstrate that blood-derived cMABs can be clonally expanded from single cells and are capable of differentiating into all 3 cardiovascular lineages, we characterized the expression of markers associated with stemness and pluripotency. Among the 4 factors (Oct3/4, Klf4, c-myc, and Sox2, which are sufficient to induce pluripotency in human fibroblasts, 17 ), cMABs, after the second to third passage or after single cell expansion, expressed Oct3/4, Klf4, and c-myc, whereas Sox2 expression was below the detection limit ( Figure 4A through 4D) . The expression of the active Oct4A isoform was confirmed by immunostaining with an Oct4A antibody and by subcloning and sequencing of the Oct4A specific PCR product (see the Online Data Supplement). However, whereas c-myc and Klf4 were expressed at levels similar to embryonic stem cells, expression of Oct3/4 was lower (Ͻ10%) in cMABs compared to embryonic stem cells ( Figure 4A and 4B) . Moreover, another important stem cell marker, Nanog, 35, 36 was not detected (Figure 4A ), whereas the endodermal transcription factor Sox17, which plays an important role in cardiac specification 37 was abundantly expressed ( Figure 4A ).
In accordance with the expression levels observed by RT-PCR and Western blot, chromatin immunoprecipitation revealed histone modifications associated with active transcription (histone H3 acetylation and H3 lysine 4 trimethylation) and low repressive heterochromatin markers (trim- 
. Cell therapy after induction of hind limb ischemia (A and B) or myocardial infarction (MI) (C through G). A and B,
Blood-derived cMABs (1ϫ10 6 ) were injected intramuscularly after ischemia and function was analyzed 2 weeks after operation. Representative images of Doppler flow in peripheral blood-derived cMABs or PBS control group (A) and summary of data (B). nϭ4 (PBS) and nϭ7 (cMAB). *PϽ0.05. C, Pressure-volume loop analysis using Millar catheter was performed 2 weeks after induction of myocardial infarction (MI). Quantification (LVEDP and Tau) are shown. *PϽ0.01 vs sham; #PϽ0.05, ##PϽ0.01 vs MI PBS group. nϭ3 (sham), nϭ7 (PBS), and nϭ6 (cMAB). D through F, Immunofluorescent images of smooth muscle actin, von Willebrand factor (vWF), and ␣-sarcomeric actinin. Injected cells were identified by human Alu probes (E) or human nuclear antigen (hNA) (D and F). Blue arrows indicate human smooth muscle cells. The white arrow indicates hNA-positive cardiomyocytes (F). G, Human-specific RT-PCR of Tie2, troponin T, and GAPDH in hearts injected with cMAB or PBS. H, Human GAPDH was measured by quantitative real-time PCR. RNA was isolated from the total hearts of mice. Cell number was calculated by standard curves. nϭ3 (MI PBS) and nϭ5 (MI cMAB). ethylated H3 lysine 9 and trimethylated H3 lysine 27) at the Klf4 promoter region ( Figure 4E ). In contrast, the repressive histone modification trimethyl-H3 lysine 27 strongly prevails at the Sox2 promoter ( Figure 4E ). Oct3/4, which was expressed at rather low levels in cMABs compared to embryonic stem cells, demonstrated an intermediate histone modification pattern with predominantly active marks in its promoter region ( Figure 4E ). Thus, excessive transcription repressive histone modifications of Sox2 may limit the pluripotency and stemness characteristics of blood-derived cMABs.
Complementation of Sox2 Enhances Differentiation Capacity and Therapeutic Effects of cMAB
Because, of the 4 pluripotency genes, only Sox2 was completely silenced, we hypothesized that Sox2 transduction may enhance the multipotency of the cells. Therefore, we overexpressed Sox2 by lentiviral vectors and confirmed Sox2 expression by RT-PCR ( Figure 5A ), quantitative PCR (data not shown) and on protein level (Online Figure XI, A) . Sox2-transduced cMAB demonstrated a re-expression of the pluripotency associated gene Nanog ( Figure 5B and 5D ) and an increase in Oct3/4 ( Figure 5C ), although the expression was still lower compared to embryonic stem cells. To evaluate the potential of Sox2-transduced cMABs to generate progeny of the 3 germ layers, we induced differentiation in hepatocytes and neuronal cells in vitro according to published protocols. 16, 38, 39 Sox2-transduced cMABs efficiently differentiate to CK18 and ␣-fetoprotein expressing hepatocytes (Online Figure XII) , and nestin and Tuj1-positive neuronal cells (Online Figure XIII) . Endothelial and cardiac differentiation was further quantified by using reporter gene assays, in which GFP is expressed under the control of the eNOS and ␣-MHC promoter, respectively. Sox2-transduced cMABs expressed eNOS-promoter-driven GFP and formed vascular networks in vitro and vivo ( Figure 6A through 6C and data not shown). Furthermore, Sox2-transduced cMABs showed a rapid and more efficient induction of ␣MHC-promoter driven GFP expression after coculture with rat neonatal cardiomyocytes ( Figure 6D through 6F) . Importantly, Sox2-transduced cMABs but not unmodified cMABs express MHC-promoter driven GFP when exposed to conditioned medium to induce cardiac differentiation ( Figure 6G and 6H) . Differentiation to smooth muscle cells, which was very efficient in control cells (41Ϯ7.4%) was further augmented when Sox2-transduced cMABs were exposed to TGF␤ (61Ϯ9.4%, Figure 6I ). Likewise, skeletal myogenic differentiation was also increased, though not dramatically by Sox2 expression (Online Figure IV) . These data document that Sox2-transduced cells have the potency to differentiate into all 3 germ layers in vitro, at variance with untransduced cells whose potency is more restricted to solid mesoderm.
To test whether Sox2-transduced cells exhibited improved therapeutic potential, we compared the effects of injecting Sox2-transduced cMABs in comparison to GFP-transduced control cMABs in nude mice after induction of acute myocardial infarction. In mice that had been randomized to the treatments, cardiac function was significantly improved in mice receiving Sox2-overexpressing cells compared to mice treated with GFP-transduced control cells after 4 weeks ( Figure 7A ; Online Figure XIV, A and B) . In addition, measurement of cardiac function by echocardiography in a second group of mice confirmed that mice receiving Sox2-transduced cMABs showed an improved WMSI compared to PBS (84.4Ϯ11%) and GFP-transduced cMAB-treated mice (92.2Ϯ5.7%). Likewise, fractional shortening in Sox2-transduced cMAB-treated mice was 154.6Ϯ22.7% compared to PBS controls and 138.2Ϯ13.8% compared to GFPtransduced cMABs. Furthermore, administration of Sox2-overexpressing cells resulted in increased numbers of ␣-sarcomeric actinin, smooth muscle actin, and von Willebrand factor-positive human cells compared to the injection of GFP-transduced control cMAB as shown by immunostaining and quantitative PCR ( Figure 7B through 7E) . To confirm cardiac differentiation, we transplanted Sox2-transduced cMABs expressing GFP under the control of the ␣MHC promoter. GFP-expressing ␣-sarcomeric actinin positive cells were detected in the border zone of the infarcts ( Figure 7F and Online Figure XV) . These data suggest that Sox2 transduction enhances the cardiovascular repair capacity as well as the ability to differentiate to endothelial, smooth muscle and cardiac cells. However, although Sox2-transduced cMAB formed embryoid body-like structures in vitro (Online Figure XI , B and C) and differentiate to all 3 germ layers in vitro, we never observed teratoma formation when subcutaneously injecting Sox2-transduced cMABs into nude mice (6 months observation; nϭ9). Likewise, spontaneously contracting embryoid bodies did not develop in culture. These data indicate that, although Sox2 transduction led to re-expression of Nanog and increased the expression of Oct3/4, the expression levels of pluripotency genes appear to be insufficient to reprogram cMAB to fully induced pluripotent cells resembling embryonic stem cells.
Discussion
Our studies identify a novel subset of circulating human progenitor cells, that can be expanded in vitro to large numbers, are capable to differentiate into all 3 distinct cardiovascular cell lineages in vitro and in vivo, secrete proangiogenic and cardioprotective factors, and mediate significant functional improvements after therapeutic administration in models of ischemia and infarction, specifically when transduced with Sox2.
Marker expression by the isolated cells is clearly distinct from all subsets of hematopoietic or endothelial progenitor cells described so far, as shown by the absence of CD45, CD34, CD133, CXCR4 and myeloid markers, such as CD14 in bulk cultures and in single cell-derived colonies. Whereas the expression of mesenchymal markers is shared by bone marrow-derived and blood-derived MSCs and multipotent adult progenitor cells, the very high expression of the endothelial marker KDR and Tie2 is unique for the circulating cells isolated in the present study. Moreover, multipotent adult progenitor cells do not express CD73 and CD44, 21, 40 which were highly expressed on the children-derived circulating progenitor cells isolated in the present study. Phenotypically, these blood-derived cells may therefore represent a correlate of embryonic dorsal aorta-derived mesoangioblasts present after birth and in the adult. Indeed, the majority of the markers being expressed on blood-derived cMABs are similar to the marker profile of previously described mouse mesoangioblasts isolated from aorta or the heart itself (see Online Table II ) and both cell populations are positive for Nkx2.5, GATA-4, Isl-1, and Tbx-5, however both mouse and human mesoangioblasts isolated from either heart or skeletal muscle are strongly positive for alkaline phosphatase, 27, 41 whereas human cMABs, like embryonic mesoangioblasts, 16 are not (data not shown). Interpretation of the phenotype by , and cardiac function were measured by Millar catheters 4 weeks after induction of myocardial infarction. Left ventricular end diastolic pressure (LVEDP), maximum dp/dt (dp/dt max), minimum dp/dt (dp/dt min), and tau (Weiss) were measured in nϭ7 (PBS), nϭ7 (GFP), and nϭ8 (Sox2) treated mice. B, Quantification of the differentiation into cardiomyocytes, smooth muscle, and endothelial cells in hearts treated with GFP and Sox2-transfected cells by immunochemistry (B) and quantitative PCR (C). B, ␣-Sarcomeric actinin, SMA, and vWF-positive human hNA-positive cells were counted (6 to 12 sections per group). C, Quantitative PCR of human-specific troponin T (TnT), SM22, and eNOS. nϭ5. D through E, Representative immunofluorescent image of smooth muscle actin (SMA) (red) (D) and vWF (red) (E). Human nuclear antigen (hNA) (green) was used to identify human cells. Yellow arrows indicate SMA ϩ (red) or vWF ϩ (red) hNA ϩ (green) cells. Pink arrow indicates hNA ϩ /SMC Ϫ cell. F, GFP expression in section of mice after acute myocardial infarction injected with Sox2-transduced cMABs expressing ␣MHC promoterdriven GFP. Yellow arrows indicate ␣-sarcomeric actinin ϩ (red) and GFP ϩ (green) cells.
using marker gene expression obviously has its limitations, because cells may change marker gene expression during culture. However, FACS sorting revealed that the expression of CD73 defines the cell population, which gives rise to the colonies. Lineage tracing will be helpful to determine the population of the circulating versus tissue-resident mesoangioblasts in mouse models. However, such studies will not give insights into the relation of these cells in humans, and human studies are obviously complicated by ethical constraints which limit the availability of blood and tissue for research particularly in children.
The novel finding of the present study that the cultured mesoangioblast-like cells and single cell-derived colonies express 3 of 4 pluripotency genes, Oct3/4, c-Myc, and Klf4, respectively, is both exciting and intriguing. However, our findings also demonstrate that the levels of Oct3/4 expression are low compared to those observed in embryonic stem cells, whereas Klf4 and c-Myc are expressed at comparable levels. Detailed analysis of epigenetic control of the promoter regions of the pluripotency genes revealed histone modifications associated with active transcription for Klf4, but excessive repressive histone modifications at the promoter of Sox2, which was not expressed in cMABs, and active histone H3 acetylation but not H3K4 trimethylation at the Oct3/4 promoter. Thus, the active transcription of the pluripotency genes Klf4 and c-Myc in combination with KDR, which defines cardiovascular progenitor cells in human embryonic stem cells, 42 might provide a rational explanation for the capacity of mesoangioblast-like cells to differentiate into all 3 cardiovascular lineages, whereas full plasticity is limited by the rather low expression of Oct3/4 and the completely repressed transcription of Sox2. Indeed, transduction of cMABs with Sox2 induced a re-expression of Nanog and increased expression of Oct3/4, a finding which is consistent with the transcriptional network induced by Sox2. 43 Interestingly, transduction with Sox2 enhanced the differentiation capacity of cMABs to the cardiovascular lineages and significantly improved the therapeutic potential compared to control cMABs in the myocardial infarction model. Moreover, Sox2-transduced cMAB can be efficiently differentiated to cell lineages of all 3 germ layers such as hepatocytes and neuronal cells, indicating that Sox2 complements the set of pluripotency genes and reprograms cMABs. However, despite the observation that Sox2-transduced cells formed some embryoid body-like structures and differentiate to cell lineages of the 3 germ layers in vitro, we did not detect teratoma formation in vivo, indicating that the cells may not be pluripotent. This might be explained by the fact that even after Sox2 transduction the expression of Oct3/4 and Nanog was significantly lower compared to embryonic stem cells. The cells may be similar to the partially reprogrammed cells described previously. 44 In contrast to the lack of teratoma formation and full reprogramming when cMABs were transduced with Sox2, others recently have reported that adult murine neuronal stem cells can be fully reprogrammed and generated teratoma after overexpression of one single factor Oct4. 45 Interestingly, in contrast to neuronal stem cells, cMAB expressed high levels of p53 and p21, factors that have been recently shown to prevent induced pluripotent cell formation (Online Figure XVI) . 46 Nevertheless, for therapeutic purposes in the future, the lack of full pluripotency in Sox2-transduced cMABs might be an advantage by reducing the risk for adverse effects such as teratoma formation. However, the use of lentiviral vectors for transducing the cells with Sox2, as in the present study, would not be clinically applicable. First alternative strategies using plasmids and/or small molecules for reprogramming were recently described and might be helpful for clinically oriented studies. 14, [47] [48] [49] Moreover, pharmacological or genetic interventions to reduce the excessive transcriptional repressive histone modifications of the Sox2 promoter may be conceived to further increase the plasticity and therapeutic potential of this unique blood-derived cell population.
